FREDERICK, MD–(Marketwired – May 30, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating “prevention of migraine” using ActiPatch therapy. Migraine is a debilitating condition that affects more than 36 million Americans, accounting for nearly $36 billion in direct and indirect costs every year in the US alone … Continue Reading
BioElectronics Expands into Tesco in the UK Market
FREDERICK, MD–(Marketwired – May 17, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is the maker of advanced, drug-free, pain management medical devices. The Company is pleased to announce that Tesco has placed their initial order for BioElectronics’ ActiPatch® Musculoskeletal Pain Therapy devices. “We are looking forward to collaborating with this innovative retailer,” said Christopher Russell, VP of … Continue Reading
BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis
BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis FREDERICK, MD–(Marketwired – Apr 20, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, over-the-counter pain management devices. The company manufactures and markets its flagship product, ActiPatch® Chronic Musculoskeletal Pain Therapy as a drug-free, wearable … Continue Reading
BioElectronics’ ActiPatch Exhibits At Australia’s Major Pharmaceutical Event
FREDERICK, MD–(Marketwired – Mar 13, 2017) – BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced noninvasive bioelectronic pain management medical devices, is pleased to announce that its devices are being featured at the Australian Pharmacy Professional Conference and Trade Exhibition. The conference and trade exhibition is the largest pharmaceutical event in Australia with 232 exhibitors … Continue Reading
BioElectronics Announces ActiPatch® Available on Amazon
FREDERICK, MD, USA, BioElectronics Corporation (OTC Pink: BIEL), February 9, 2017 8:30 AM, the maker of advanced pain management medical devices, today announced that ActiPatch® Musculoskeletal Pain Therapy device is now available on the US Amazon.com. ActiPatch is the leading nonprescription pain therapy in the United Kingdom with over 300 reviews that rate the device … Continue Reading
BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy
FREDERICK, MD, USA, February 5, 2017 — BioElectronics Corporation (OTC Pink: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the … Continue Reading
BioElectronics Comments on its U.S. FDA’s OTC Market Clearance Application
FREDERICK, Md., Oct. 10, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced disposable electroceutical devices, announced that on Monday, October 3rd, 2016 it met with senior management from the FDA’s Division of Neurological and Physical Medicine Devices, including the Deputy Division Director, the Acting Branch Chief of the Physical Medicine and … Continue Reading
BioElectronics Company Update: Sept 30, 2016
Reflexonic, LLC On September 9, 2016, we signed an Exclusive Licensing and Supply Agreement with Reflexonic, LLC. Reflexonic sells and distributes urological medical devices, products, and related medical products. Reflexonic will assist in the development of urological products for the treatment of overactive bladder, interstitial cystitis and bladder pain syndrome by providing device therapeutic specifications, … Continue Reading
BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication
FREDERICK, Md., Sept. 28, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced neuromodulation medical devices announced that it has submitted a paper: “ActiPatch© Central Sensitization Therapy: A Chronic Back Pain Registry Study of Pain Relief & Analgesic Adverse Effects” for publication. The study reports that the majority of chronic back pain sufferers have … Continue Reading
BioElectronics Launches ActiPatch®, Musculoskeletal Pain Therapy In Sweden
FREDERICK, Md., Sept.13, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Sweden distributor, Harmony Health, Sweden, AB , has received initial stocking orders for Pharmacy Heart,www.apotekhjartat.se and the Life health products chain, www.lifebutiken.se. Life health products are a chain of 220 stores and Pharmacy … Continue Reading